272
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Association between altered lipid profiles and attention deficit hyperactivity disorder in boys

Pages 361-366 | Received 15 Jan 2018, Accepted 11 Apr 2018, Published online: 24 Apr 2018

References

  • Scahill L, Schwab-Stone M. Epidemiology of ADHD in school-age children. Child Adolesc Psychiatr Clin N Am. 2000;9:541–555.
  • American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-IV-R). 4th ed. Washington (DC): American Psychiatric Association; 2000.
  • Biederman J. Attention-deficit/hyperactivity disorder: a selective overview. Biol. 2005;57:1215–1220.
  • Harpin VA. The effect of ADHD on the life of an individual, their family, and community from preschool to adult life. Arch Dis Child. 2005;90:2–7.
  • Thapar A, Cooper M. Attention deficit hyperactivity disorder. Lancet. 2006;387:1240–1250.
  • Young GS, Maharaj NJ, Conquer JA. Blood phospholipid fatty acid analysis of adults with and without attention deficit/hyperactivity disorder. Lipids. 2004;39:117–123.
  • Chang JPC, Jingling L, Huang YT, et al. Delay aversion, temporal processing, and N-3 fatty acids intake in children with attention-deficit/hyperactivity disorder (ADHD). Clin Psychol Sci. 2016;4:1094–1103.
  • Parletta N, Niyonsenga T, Duff J. Omega-3 and omega-6 polyunsaturated fatty acid levels and correlations with symptoms in children with attention deficit hyperactivity disorder, autistic spectrum disorder and typically developing controls. PLoS One. 2016;11:e0156432.
  • Bloch MH, Qawasmi A. Omega-3 fatty acid supplementation for the treatment of children with attention-deficit/hyperactivity disorder symptomatology: systematic review and meta-analysis. J Am Acad Child Adolesc Psychiatry. 2011;50:991–1000.
  • Sonuga-Barke EJ, Brandeis D, Cortese S, et al. Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. Am J Psychiatry. 2013;170:275–289.
  • Cooper RE, Tye C, Kuntsi J, et al. The effect of omega-3 polyunsaturated fatty acid supplementation on emotional dysregulation, oppositional behaviour and conduct problems in ADHD: a systematic review and meta-analysis. J Affect Disord. 2016;190:474–482.
  • Königs A, Kiliaan AJ. Critical appraisal of omega-3 fatty acids in attention-deficit/hyperactivity disorder treatment. Neuropsychiatr Dis Treat. 2016;12:1869–1882.
  • Breitling R. Greased hedgehogs: new links between hedgehog signaling and cholesterol metabolism. Bioessays. 2007;29:1085–1094.
  • Saher G, Simons M. Cholesterol and myelin biogenesis. Subcell Biochem. 2010;51:489–508.
  • Allen JA, Halverson-Tamboli RA, Rasenick MM. Lipid raft microdomains and neurotransmitter signalling. Nat Rev Neurosci. 2007;8:128–140.
  • Aneja A, Tierney E. Autism: the role of cholesterol in treatment. Int Rev Psychiatry. 2008;20:165–170.
  • Troisi A. Low cholesterol is a risk factor for attentional impulsivity in patients with mood symptoms. Psychiatry Res. 2011;188:83–87.
  • Engelberg H. Low serum cholesterol and suicide. Lancet. 1992;339:727–729.
  • Kaufman J, Birmaher B, Brent D, et al. Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry. 1997;36:980–988.
  • Gökler B, Ünal F, Pehlivantürk B, et al. Reliability and validity of schedule for affective disorders and schizophrenia for school age children-present and lifetime version-Turkish version (K-SADS-PL-T) (in Turkish). Turkish J Child Adolesc Psychiatry. 2004;11:109–116.
  • Wechsler D. WISC-R manual for the Wechsler Intelligence Scale for Children-Revised. New York (NY): Psychological Corporation; 1974.
  • Ercan E, Amado S, Somer O, et al. Development of a test battery for the assessment of attention deficit hyperactivity disorder. Turk J Child Adolesc Ment Health. 2001;8:132–144.
  • Turgay A. Cocuk ve Ergenlerde Davranım Bozuklukları için DSM- IV’e Dayalı Tarama ve Değerlendirme Ölçeği (Unpublished scale); 1995.
  • Conners CK. Manual for the Conners’ Rating Scales-revised. North Tonawanda (NY): Multi-Health Systems; 1997.
  • Kaner S, Buyukozturk S, Iseri E, et al. Validity and reliability study of the Conners’ Parent Rating Scale Revised Long Form. Antalya, XVI: National Child and Adolescent Psychiatry Meeting (abstract); 2006.
  • Goyette CH, Conners CK, Ulrich RF. Normative data on revised Conners parent and teacher rating scales. J Abnorm Child Psychol. 1978;6:221–236.
  • Dereboy C, Senol S, Sener S, et al. Validity of the Turkish version short form Conners’ teacher and parent rating scales. Turk Psikiyatri Derg. 2007;18:48–58.
  • Sener S, Dereboy C, Dereboy IF, et al. Conners’ teacher rating scale Turkish version-I. Turk J Child Adolesc Ment Health. 1993;2:131–141.
  • Friedewald WT, Lewy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–502.
  • Pinho R, Wang B, Becker A, et al. Attention-deficit/hyperactivity disorder is associated with reduced levels of serum low-density lipoprotein cholesterol in adolescents. Data from the population-based German KiGGS study. World J Biol Psychiatry. 2017;15:1–29.
  • Irmisch G, Thome J, Reis O, et al. Modified magnesium and lipoproteins in children with attention deficit hyperactivity disorder (ADHD). World J Biol Psychiatry. 2011;12:63–65.
  • Irmisch G, Richter J, Thome J, et al. Altered serum mono- and polyunsaturated fatty acid levels in adults with ADHD. Adhd Atten Def Hyp Disord. 2013;5:303–311.
  • Spahis S, Vanasse M, Bélanger SA, et al. Lipid profile, fatty acid composition and pro- and anti-oxidant status in pediatric patients with attention-deficit/hyperactivity disorder. Prostaglandins Leukot Essent Fatty Acids. 2008;79:47–53.
  • Chen JR, Hsu SF, Hsu CD, et al. Dietary patterns and blood fatty acid composition in children with attention-deficit hyperactivity disorder in Taiwan. J Nutr Biochem. 2004;15:467–472.
  • Mufti RM, Balon R, Arfken CL. Low cholesterol and violence. Psychiatr Serv. 1998;49:221–224.
  • Rabe-Jablonska J, Poprawska I. Levels of serum total cholesterol and LDL-cholesterol in patients with major depression in acute period and remission. Med Sci Monit. 2000;6:539–547.
  • Lalovic A, Levy E, Luheshi G, et al. Cholesterol content in brains of suicide completers. Int J Neuropsychopharmacol. 2007;10:159–166.
  • Singh P, Paila YD, Chattopadhyay A. Differential effects of cholesterol and 7-dehydrocholesterol on the ligand binding activity of the hippocampal serotonin(1A) receptor: implications in SLOS. Biochem Biophys Res Commun. 2007;358:495–499.
  • Gil C, Cubi R, Blasi J, et al. Synaptic proteins associate with a sub-set of lipid rafts when isolated from nerve endings at physiological temperature. Biochem Biophys Res Commun. 2006;348:1334–1342.
  • Kavoor AR, Ram D, Mitra S. Lipid correlates of attentional impulsivity in first episode mania: results from an Indian population. Indian J Psychol Med. 2014;36:378–384.
  • Vevera J, Zukov I, Morcinek T, et al. Cholesterol concentrations in violent and non-violent women suicide attempters. Eur Psychiatry. 2003;18:23–27.
  • Tseng WL, Kawabata Y, Gau SS, et al. Relations of inattention and hyperactivity/impulsivity to preadolescent peer functioning: the mediating roles of aggressive and prosocial behaviors. J Clin Child Adolesc Psychol. 2012;41:275–287.
  • Hibbeln JR, Salem JN. Dietary polyunsaturated fatty acids and depression: when cholesterol does not satisfy. Am J Clin Nutr. 1995;62:1–9.
  • Sinclair AJ, O’dea K, Dunstan G, et al. Effects on plasma lipids and fatty acid composition of very low fat diets enriched with fish or kangaroo meat. Lipids. 1987;22:523–529.
  • Farquharson J, Cockburn F, Patrick WA, et al. Infant cerebral cortex phospholipid fatty-acid composition and diet. Lancet. 1992;340:810–813.
  • Makrides M, Simmer K, Goggin M, et al. Erythrocyte docosahexaenoic acid correlates with the visual response of healthy, term infants. Pediatr Res. 1993;33:425–427.
  • Fedorova I, Hussein N, Baumann MH, et al. An n-3 fatty acid deficiency impairs rat spatial learning in the Barnes maze. Behav Neurosci. 2009;123:196–205.
  • Chalon S. Omega-3 fatty acids and monoamine neurotransmission. Prostaglandins Leukot Essent Fatty Acids. 2006;75:259–269.
  • Levant B, Radel JD, Carlson SE. Decreased brain docosahexaenoic acid during development alters dopamine-related behaviors in adult rats that are differentially affected by dietary remediation. Behav Brain Res. 2004;152:49–57.
  • Sikora DM, Pettit-Kekel K, Penfield J, et al. The near universal presence of autism spectrum disorders in children with Smith-Lemli-Opitz syndrome. Am J Med Genet A. 2006;140:1511–1518.
  • Cooper MK, Wassif CA, Krakowiak PA, et al. A defective response to Hedgehog signaling in disorders of cholesterol biosynthesis. Nat Genet. 2003;33:508–513.
  • Ribes V, Briscoe J. Establishing and interpreting graded Sonic Hedgehog signaling during vertebrate neural tube patterning: the role of negative feedback. Cold Spring Harb Perspect Biol. 2009;1:a002014.
  • Palma V, Ruiz i Altaba A. Hedgehog-GLI signaling regulates the behavior of cells with stem cell properties in the developing neocortex. Development. 2004;131:337–345.
  • Roessler E, Belloni E, Gaudenz K, et al. Mutations in the human Sonic Hedgehog gene cause holoprosencephaly. Nat Genet. 1996;14:357–360.
  • Caruso PA, Poussaint TY, Tzika AA, et al. MRI and 1H MRS findings in Smith-Lemli-Opitz syndrome. Neuroradiology. 2004;46:3–14.
  • Valera EM, Faraone SV, Murray KE, et al. Meta-analysis of structural imaging findings in attention-deficit/hyperactivity disorder. Biol Psychiatry. 2007;61:1361–1369.
  • Thierfelder W, Dortschy R, Hintzpeter B, et al. Biochemical measures in the German Health Interview and Examination Survey for Children and Adolescents (KiGGS). Bundesgesundheitsbl. 2007;50:757–770.
  • Charach G, Kaysar N, Grosskopf I, et al. Methylphenidate has positive hypocholesterolemic and hypotriglyceridemic effects: new data. J Clin Pharmacol. 2009;49:848–851.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.